ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 135 filers reported holding ASCENDIS PHARMA A/S in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,122,652 | +1.4% | 396,440 | -3.4% | 0.07% | +4.7% |
Q2 2023 | $36,626,714 | -28.2% | 410,384 | -13.8% | 0.06% | -32.6% |
Q1 2023 | $51,038,950 | -4.4% | 476,021 | +8.9% | 0.10% | -20.2% |
Q4 2022 | $53,401,449 | +9.2% | 437,251 | -7.7% | 0.12% | +9.2% |
Q3 2022 | $48,895,000 | +16.4% | 473,519 | +4.8% | 0.11% | +19.8% |
Q2 2022 | $42,001,000 | -19.5% | 451,801 | +1.6% | 0.09% | -13.3% |
Q1 2022 | $52,170,000 | -8.3% | 444,559 | +5.2% | 0.10% | -1.9% |
Q4 2021 | $56,865,000 | -8.3% | 422,691 | +8.6% | 0.11% | -17.7% |
Q3 2021 | $62,039,000 | +58.1% | 389,223 | +30.5% | 0.13% | +49.4% |
Q2 2021 | $39,247,000 | +16.0% | 298,321 | +13.7% | 0.09% | +2.4% |
Q1 2021 | $33,830,000 | -16.6% | 262,392 | +7.9% | 0.08% | -19.0% |
Q4 2020 | $40,551,000 | +11.9% | 243,102 | +3.5% | 0.10% | 0.0% |
Q3 2020 | $36,229,000 | +62.6% | 234,774 | +55.8% | 0.10% | +52.2% |
Q2 2020 | $22,281,000 | +129.6% | 150,652 | +74.8% | 0.07% | +91.7% |
Q1 2020 | $9,705,000 | +5.8% | 86,186 | +30.8% | 0.04% | +33.3% |
Q4 2019 | $9,169,000 | +46.4% | 65,908 | +1.4% | 0.03% | +68.8% |
Q3 2019 | $6,262,000 | +23.4% | 65,009 | +47.5% | 0.02% | -5.9% |
Q2 2019 | $5,075,000 | +71.8% | 44,071 | +75.6% | 0.02% | +70.0% |
Q1 2019 | $2,954,000 | – | 25,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 133,691 | $13,805,000 | 36.44% |
RA Capital Management | 7,567,900 | $781,462,000 | 16.67% |
Q Global Advisors, LLC | 145,209 | $16,699,000 | 11.49% |
BERYLSON CAPITAL PARTNERS, LLC | 51,000 | $5,266,000 | 8.70% |
Spyglass Capital Management LLC | 949,915 | $98,088,000 | 6.94% |
Paradigm Biocapital Advisors LP | 497,347 | $51,356,000 | 6.85% |
Avoro Capital Advisors LLC | 2,850,000 | $294,291,000 | 5.44% |
Deep Track Capital, LP | 1,000,000 | $103,260,000 | 4.73% |
Finepoint Capital LP | 123,400 | $12,742,000 | 4.19% |
Deep Track Capital, LP | 800,000 | $82,608,000 | 3.78% |